You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Dow
Merck
Mallinckrodt
Johnson and Johnson

Last Updated: March 8, 2021

DrugPatentWatch Database Preview

Gentamicin sulfate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for gentamicin sulfate and what is the scope of patent protection?

Gentamicin sulfate is the generic ingredient in twelve branded drugs marketed by Schering, Pharmafair, Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Taro, Teligent, King Pharms, Bristol, Intl Medication, Abbott, Fresenius Kabi Usa, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, B Braun, Baxter Hlthcare, Pharmacia And Upjohn, Novartis, Akorn, Fera Pharms Llc, Allergan, Alcon Pharms Ltd, Bausch And Lomb, Paco, Perrigo Co Tennessee, and Sandoz Inc, and is included in sixty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for gentamicin sulfate. Twenty-five suppliers are listed for this compound.

Summary for gentamicin sulfate
US Patents:0
Tradenames:12
Applicants:34
NDAs:61
Drug Master File Entries: 15
Suppliers / Packagers: 25
Clinical Trials: 12
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in gentamicin sulfate?gentamicin sulfate excipients list
DailyMed Link:gentamicin sulfate at DailyMed
Drug Sales Revenue Trends for gentamicin sulfate

See drug sales revenues for gentamicin sulfate

Recent Clinical Trials for gentamicin sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Oslo University HospitalPhase 1/Phase 2
Kaiser PermanentePhase 2
London School of Hygiene and Tropical MedicinePhase 3

See all gentamicin sulfate clinical trials

Pharmacology for gentamicin sulfate

US Patents and Regulatory Information for gentamicin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Spec GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062340-001 Mar 28, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062366-001 Aug 4, 1983 AP RX No Yes   Start Trial   Start Trial   Start Trial
Abbott GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062413-010 Aug 11, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
King Pharms APOGEN gentamicin sulfate INJECTABLE;INJECTION 062289-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo New York GENTAMICIN SULFATE gentamicin sulfate CREAM;TOPICAL 062307-001 Approved Prior to Jan 1, 1982 AT RX No Yes   Start Trial   Start Trial   Start Trial
Fougera Pharms Inc GENTAMICIN SULFATE gentamicin sulfate CREAM;TOPICAL 062531-001 Jul 5, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Solopak GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062507-002 Jun 6, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
McKinsey
Harvard Business School
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.